Literature DB >> 8398258

Predictive testing for germline mutations in the p53 gene: are all the questions answered?

R A Eeles1.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8398258     DOI： 10.1016/0959-8049(93)90001-v

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  7 in total

1.  Regional differences in breast cancer biomarkers in american Indian and Alaska native women.

Authors:  Judith S Kaur; Robert A Vierkant; Timothy Hobday; Daniel Visscher
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-03       Impact factor: 4.254

Review 2.  Li-Fraumeni syndrome--a molecular and clinical review.

Authors:  J M Varley; D G Evans; J M Birch
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

3.  Childhood predictive genetic testing for Li-Fraumeni syndrome.

Authors:  D G Evans; P Lunt; T Clancy; R Eeles
Journal:  Fam Cancer       Date:  2009-04-30       Impact factor: 2.375

Review 4.  Referral for cancer genetics consultation: a review and compilation of risk assessment criteria.

Authors:  H Hampel; K Sweet; J A Westman; K Offit; C Eng
Journal:  J Med Genet       Date:  2004-02       Impact factor: 6.318

5.  Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome.

Authors:  T Frebourg; N Barbier; Y X Yan; J E Garber; M Dreyfus; J Fraumeni; F P Li; S H Friend
Journal:  Am J Hum Genet       Date:  1995-03       Impact factor: 11.025

6.  A possible screening test for inherited p53-related defects based on the apoptotic response of peripheral blood lymphocytes to DNA damage.

Authors:  R S Camplejohn; P Perry; S V Hodgson; G Turner; A Williams; C Upton; C MacGeoch; S Mohammed; D M Barnes
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

Review 7.  The genetics of breast and ovarian cancer.

Authors:  D Ford; D F Easton
Journal:  Br J Cancer       Date:  1995-10       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.